[144] CG Oncology, Inc. Common stock SEC Filing

Rhea-AI Filing Summary

CG Oncology, Inc. (CGON) filing a Form 144 to report a proposed sale of common stock. The notice shows 27,015 shares to be sold through Morgan Stanley Smith Barney LLC on 09/05/2025 on NASDAQ with an aggregate market value of $835,844.10 and 76,247,581 shares outstanding. The securities were acquired on 09/05/2025 by exercise of stock options from the issuer, paid in cash. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice reporting option exercise and planned sale of 27,015 shares.

This Form 144 documents a proposed sale tied to an option exercise on the same date, routed through Morgan Stanley Smith Barney LLC for execution on NASDAQ, with an aggregate market value of $835,844.10. The filing indicates no other sales in the past three months and includes the standard attestation about material non-public information. The disclosure appears procedural and consistent with compliance reporting for insiders monetizing exercised options.

Corporate Governance Expert

TL;DR: Compliance-focused filing; shows standard representations and broker details for planned disposal.

The notice provides the issuer, broker, quantity, acquisition method (stock option exercise), payment type (cash), and execution venue. It contains the usual signature attestation regarding material information and a blank remark section. From a governance perspective this is a standard Form 144 notification to satisfy Rule 144 requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	27015	835844.10	76247581	09/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Exercise of Stock Options	Issuer			27015	09/05/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CGON's Form 144 report?

The filing reports a proposed sale of 27,015 shares of CG Oncology common stock to be executed on 09/05/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

How were the shares acquired that are being sold?

The shares were acquired on 09/05/2025 by exercise of stock options from the issuer and payment was made in cash.

What is the aggregate market value reported for the proposed sale?

The aggregate market value of the shares to be sold is reported as $835,844.10.

Has the filer sold any CGON securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker listed on the Form 144?

The broker is listed as Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.